跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Designs a Drug Molecule from Scratch

1Why Designing a Drug Molecule Is Hard2Turning Molecules into Something a Machine Can Read3How Generative Models Propose New Molecules4Scoring and Filtering the Candidates5Testing, Learning, and Improving the Design
Why Designing a Drug Molecule Is Hard

Why Screening Stalls and Where AI Steps In

3 / 3
Look at the two limits together. A physical screen can only return what is already on the shelf, and its cost rises with every compound it tests. Those are not equipment problems — they are built into the approach. That is the opening for AI: rather than sampling a shelf, propose structures that were never on it, then rank them so you only make and test the few most promising. The experiments still happen; what changes is which ones you choose to run.
0:00 / 0:00

What limits a physical screen

A screening campaign can only return compounds that are physically present in its collection, and its cost scales with how many it tests. Both limits are structural, not a matter of better equipment: the collection is finite and small relative to chemical space, and every additional compound costs another assay.

Where AI changes the arithmetic

AI does not make the space smaller. It changes the strategy from sampling an existing shelf to proposing new structures and ranking them, so experimental effort is concentrated on a short list of candidates that are more likely to be worth making.

Everything so far has been about the problem, not the method. How a molecule becomes machine-readable data is the next step, and it is what makes generation and comparison possible at all.

上一页3 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion